Registration Number
0223U002390,
0120U000072
, R & D reports
Title
To develop and improve methods of diagnostics and surgical treatment of complicated forms of cardiac mixomas
popup.stage_title
Head
Vitovskyі Rostislav M., Доктор медичних наук
Registration Date
16-02-2023
Organization
National institute of CVS of Amosov name. Academy of medical science Ukraine
popup.description2
It was found that out of 868 cases of this pathology, recurrences of cardiac myxoma were found in 16 patients, which was 1.8%. Embolism of peripheral arteries as a complication of the course of the disease was detected in 58 patients (6.3%). Ischemic heart disease, which required surgical correction, accompanied 39 (4.5%) cases of heart tumors. Damage to the valvular system of the heart occurred in 70 (8.1) patients. The occurrence of coronary artery embolism in heart tumors is extremely rare and, according to our data, reaches 0.2% of all patients with heart neoplasms. For the correction of coronary artery lesions in heart tumors, the entire range of surgical techniques is used, including coronary artery stenting, aorto-coronary bypass, removal of the myocardial bridge, and ventricular aneurysm resection. Repeated operations were performed in 12 patients, which was associated with the recurrence of the tumor process or the occurrence of a tumor in places other than the primary localization. The frequency of detection of "myxoma syndrome" was 0.8% of cases (in which the need for repeated operations can reach 42%). Radicality of the removal of the heart mix largely depends not only on the volume of excision of the affected tissues, but also on the adequacy of treatment of the vessels feeding the neoplasm.
The frequency of concomitant lesions of the valvular system in myxomas of the heart is 8.1%. Among the main mechanisms of damage to the heart valves, such as mechanical damage to the valves (43.2%), involvement of the valve apparatus in the tumor process (14.9%), and dilatation of the heart valves (41.8%) should be noted. Both plastic methods (61.1%) and valve prosthetics (20.9%) are used to restore the function of damaged valves in heart myxomas, depending on the nature of their destruction or involvement in the tumor process.
Product Description
popup.authors
Isaienko Volodymyr V.
Babadzhanov Kalandar B.
Vitovsky Rostyslav M.
Zakharova Valentyna P.
Kupchiskiy Olexandr Volodimirovich
Martishchenko Igor V.
Pishchurin Oleksandr Anatoliyovych
Rudenko Olena V.
Semeniv Petro M.
Yakovenko Inna G.
popup.nrat_date
2023-02-16
